Get the Stockscreener App
80.90
0.31%
-0.25
Prestige Consumer Healthcare Inc stock is traded at $80.90, with a volume of 855.80K.
It is down -0.31% in the last 24 hours and down -5.80% over the past month.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
See More
Previous Close:
$81.15
Open:
$81.27
24h Volume:
855.80K
Relative Volume:
2.42
Market Cap:
$4.21B
Revenue:
$1.11B
Net Income/Loss:
$205.95M
P/E Ratio:
19.68
EPS:
4.11
Net Cash Flow:
$254.64M
1W Performance:
-3.04%
1M Performance:
-5.80%
6M Performance:
+3.12%
1Y Performance:
+16.20%
1-Day Range:
$80.05
$81.33
1-Week Range:
$78.83
$85.29
52-Week Range:
$64.94
$90.04
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Name
Prestige Consumer Healthcare Inc
Sector
Phone
(914) 524-6800
Address
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
80.90 | 4.21B | 1.11B | 205.95M | 254.64M | 4.11 |
|
RGC
Regencell Bioscience Holdings Ltd
|
17.40 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
156.17 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.38 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.76 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-24 | Downgrade | Sidoti | Buy → Neutral |
| Jun-21-24 | Upgrade | DA Davidson | Neutral → Buy |
| Nov-17-22 | Initiated | Canaccord Genuity | Buy |
| May-10-22 | Upgrade | Jefferies | Hold → Buy |
| May-09-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-07-20 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-29-20 | Upgrade | Sidoti | Neutral → Buy |
| Apr-14-20 | Downgrade | Jefferies | Buy → Hold |
| Apr-07-20 | Resumed | Sidoti | Neutral |
| Mar-26-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-24-20 | Initiated | Oppenheimer | Perform |
| Mar-19-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-04-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jun-02-17 | Upgrade | Jefferies | Underperform → Hold |
| May-22-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-27-16 | Reiterated | B. Riley & Co. | Buy |
| Nov-17-16 | Initiated | Gabelli & Co | Buy |
| Aug-12-16 | Upgrade | Sidoti | Neutral → Buy |
| Mar-08-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Feb-05-16 | Initiated | Piper Jaffray | Overweight |
| Nov-30-15 | Downgrade | Jefferies | Hold → Underperform |
| Apr-28-14 | Reiterated | B. Riley & Co. | Buy |
| Apr-28-14 | Reiterated | Oppenheimer | Outperform |
| Jul-09-13 | Initiated | B. Riley & Co. | Buy |
View All
Prestige Consumer Healthcare Inc Stock (PBH) Latest News
Zacks Research Issues Positive Forecast for PBH Earnings - Defense World
Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination - TAPinto
Little Remedies Honey Cough Syrup recalled over safety concerns - WCNC
Medtech Products Inc. Issues Nationwide Recall of Little Remedie - GuruFocus
Prestige Consumer (PBH) Recalls Little Remedies Honey Cough Syrup Amid Safety Concerns | PBH Stock News - GuruFocus
Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination - SINA HONG KONG LIMITED
Medtech Products Inc. Issues Nationwide Recall of Little - GlobeNewswire
Little Remedies Honey Cough Syrup Recalled Nationwide Due to Bacterial Risk | PBH Stock News - Stock Titan
Yousif Capital Management LLC Sells 382 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Long Term Trading Analysis for (PBH) - news.stocktradersdaily.com
5 Undervalued Semiconductor Stocks You Can Buy Now and Hold Long-Term - The Globe and Mail
Should You Continue to Hold Prestige Consumer Stock in Your Portfolio? - sharewise
Global Dental Floss Industry Report | Product Innovation Boosts - openPR.com
Those who invested in Prestige Consumer Healthcare (NYSE:PBH) five years ago are up 112% - simplywall.st
Wealth Enhancement Advisory Services LLC Grows Stock Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Here's How Much You Would Have Made Owning Prestige Consumer Stock In The Last 15 Years - Benzinga
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer - GuruFocus
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference - The Manila Times
Prestige Consumer Healthcare Inc. to Present at the - GlobeNewswire
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and ... - Bluefield Daily Telegraph
Prestige Consumer Healthcare Fireside Chat: Strategic Insights Coming at Major Oppenheimer Conference - Stock Titan
Millennium Management LLC Trims Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today - Benzinga
Stocks in play: BCE Inc. - The Globe and Mail
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick - Yahoo Finance
Hogs Close Mixed on Monday - The Globe and Mail
Zacks Research Issues Optimistic Outlook for PBH Earnings - Defense World
Tidal Investments LLC Sells 1,380 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Equities Analysts Set Expectations for PBH Q1 Earnings - Defense World
Cetera Investment Advisers Invests $413,000 in Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Is Bio-Techne Stock the Right Pick for Your Portfolio Now? - The Globe and Mail
The Sandlot Star Patrick Renna Teams Up with Dramamine® to Revisit an Iconic SceneThis Time, Puke Free - The Malaysian Reserve
Lice Treatment Market Deep Research Report Identifies Key TrendsPrestige Consumer Healthcare, Reckitt - openPR.com
Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock? - Nasdaq
Prestige Consumer Healthcare Inc. (NYSE:PBH) Holdings Decreased by Nuveen Asset Management LLC - Defense World
Deutsche Bank AG Purchases 14,929 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Prestige Consumer Healthcare Inc. (NYSE:PBH) Position Reduced by Ameriprise Financial Inc. - Defense World
Prestige Consumer Healthcare (NYSE:PBH) Upgraded to “Buy” at StockNews.com - Defense World
Weekly Recap: 14 Health Press Releases You Need to See - Yahoo Finance
Prestige's Diversified Portfolio and Strong Execution Should Drive Steady Growth Across Categories - Morningstar
Prestige Consumer Stock Up 8% Since Q4 Earnings Beat, Margin Increase - MSN
U.S. News Announces the 2025-2026 Best OTC Medicine & Health Products - Morningstar
Prestige Consumer Healthcare Inc. (NYSE:PBH) Q4 2025 Earnings Call Transcript - Insider Monkey
US News 2025 Best OTC Products: Nature Made Leads with 7 Top Rankings in Expert Survey - Stock Titan
How To Trade (PBH) - news.stocktradersdaily.com
Prestige Consumer Healthcare’s Earnings Call Highlights Growth Amid Challenges - TipRanks
Aussie Stocks Hold Steady With US-China Trade Optimism - Finimize
Prestige Consumer Healthcare (NYSE:PBH) Cut to “Hold” at StockNews.com - Defense World
Prestige Consumer Healthcare Full Year 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Prestige Consumer Healthcare (NYSE:PBH) Stock Rating Upgraded by Royal Bank of Canada - Defense World
Jefferies raises Prestige Brands target to $85, maintains Hold rating By Investing.com - Investing.com India
Prestige Consumer Healthcare Inc Stock (PBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.07%
0.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):